Teva is licensed to launch a generic version of Victoza as of Dec. 22, 2023 as the result of its settlement with Novo Nordisk, which manufactures the branded version of the drug.
Industry groups have voiced their support for the Center for Medicare and Medicaid Services' rejection of Washington state’s below-cost dispensing fee. The agency said the practice was inconsistent with federal Medicaid rules.
Dr. Reddy's XCEED customer service portal enables online transactions and access to real-time information regarding their active pharmaceutical ingredient orders.
This is the first Food and Drug Administration approval of a pediatric indication for complicated intra-abdominal infections and complicated urinary tract infections in more than a decade, Allergan said.
